Company / SG&A per Share
Progyny SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.72
FY2025
5-year range
$0.59 / $1.72
FY2021-FY2025
Trend
+36.2%
vs FY2024
Sector context
#116 of 150
Health Care
What the data says
Progyny's sg&a per share of $1.72 is lower than 77% of companies in the Health Care sector (FY2025). SG&A per Share has increased for 5 consecutive years, from $0.47 in FY2020 to $1.72 in FY2025.
Based on SEC 10-K filings.
1.72 in FY2025 with a 5-year CAGR of +29.6%.
Increased from $1.26 to $1.72 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +16.9%
- 5-Year CAGR
- +29.6%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 150This company $1.72 Sector average $11878.17
▼
-100.0% below sector average
Key checks
Key Insights
- Progyny's sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 36.2% year-over-year.
- Ranks #116 out of 150 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.72 | +36.2% |
| FY2024 | $1.27 | +0.8% |
| FY2023 | $1.26 | +16.3% |
| FY2022 | $1.08 | +81.7% |
| FY2021 | $0.59 | +26.0% |
| FY2020 | $0.47 | -59.1% |
| FY2019 | $1.15 | -59.0% |
| FY2018 | $2.82 | +13.0% |
| FY2017 | $2.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026